Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Condition:   Congestive Heart Failure Interventions:   Drug: OPC-61815;   Drug: Tolvaptan Tab 15 MG Sponsor:   Otsuka Pharmaceutical Co., Ltd. Recruiting

Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials